Long
PETX: Bearcat or Bulldog?
Is there an argument for mid-term profits in Aratana Therapeutics, Inc., (PETX)?
The stock is in a lower trading range, while the markets surge. a low curve on a high crest?
The stock is in a lower trading range, while the markets surge. a low curve on a high crest?
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.